Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/15/2012EP1615633B1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
08/15/2012EP1594524B1 Use of tryptanthrin compounds for immune potentiation
08/15/2012EP1566378B1 Isoindoline derivative
08/15/2012EP1461347B8 2-o-(beta-d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it
08/15/2012EP1438295B1 Azole derivatives and pharmaceutical compositions containing them
08/15/2012EP1420716B1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
08/15/2012EP1383735B1 Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
08/15/2012EP1379242B1 Method for treatment of cancer and compositions for use therein
08/15/2012EP1315691B1 Method of obtaining a hydroxytyrosol-rich composition from vegetation water
08/15/2012CN1976938B Thienopyrazole derivative having PDE7 inhibitory activity
08/15/2012CN1895264B Medicinal use of quercetin-3-0-beta-D-glucancoside
08/15/2012CN1882693B Polyethyleneglycol-modified lipid compounds and uses thereof
08/15/2012CN1867550B Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders
08/15/2012CN1688322B Antiseptic solutions containing silver chelated with polypectate and EDTA
08/15/2012CN1646102B Pharmaceutical preparation containing oxycodone and naloxone
08/15/2012CN1351498B Pyrrolotriazines inhibitors of kinases
08/15/2012CN102640001A Biomarkers predictive of progression of fibrosis
08/15/2012CN102639700A Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products
08/15/2012CN102639548A Process for preparing ruthenium(0)-olefin complexes
08/15/2012CN102639543A Silyl polymeric benzoic acid ester compounds, uses, and compositions thereof
08/15/2012CN102639539A Process for the preparation of imidazo[2,1-b][1,3]benzothiazole derivatives
08/15/2012CN102639537A Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof
08/15/2012CN102639536A Anhydrate forms of a pyridine derivative
08/15/2012CN102639534A Purine derivatives useful as hsp90 inhibitors
08/15/2012CN102639533A Azacyclic spiro derivatives
08/15/2012CN102639532A Fused triazole amines as P2X7 modulators
08/15/2012CN102639531A Anhydrate of triotropium bromide
08/15/2012CN102639530A Morpholinothiazoles as alpha 7 positive allosteric modulators
08/15/2012CN102639528A Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
08/15/2012CN102639527A Novel phenylpyridine derivative and medicinal agent comprising same
08/15/2012CN102639526A L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands
08/15/2012CN102639523A Sustituted (heteroarylmethyl) thiohydantoins as anticancer drugs
08/15/2012CN102639522A Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and methods of making the same
08/15/2012CN102639520A Sialochimeric compounds
08/15/2012CN102639518A Novel phenol derivative
08/15/2012CN102639516A 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazine derivatives
08/15/2012CN102639515A Compounds as lysophosphatidic acid receptor antagonists
08/15/2012CN102639513A Sphingosine kinase inhibitors
08/15/2012CN102639511A Heterocyclyl substituted arylindenopy-rimidines and their use as highly selective adenosine A2A receptor antagonists
08/15/2012CN102639510A Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea and salts thereof
08/15/2012CN102639506A 5- (3, 4-dichloro-phenyl) -n- (2-hydroxy-cyclohexyl) -6- (2,2, 2-trifluoro-ethoxy) -nico tinamide and salts thereof as HDL cholesterol raising agents
08/15/2012CN102639505A 2-pyridone compounds used as inhibitors of neutrophil elastase
08/15/2012CN102639504A Heterocyclic antiviral compounds
08/15/2012CN102639503A Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
08/15/2012CN102639499A Processes and intermediates
08/15/2012CN102639497A Compounds inhibitors of enzyme lactate dehydrogenase (LDH) and pharmaceutical compositions containing these compounds
08/15/2012CN102639496A Lysine specific demethylase-1 inhibitors and their use
08/15/2012CN102639495A Pyrrolidine GPR40 Modulators
08/15/2012CN102639494A Sulphone compounds and methods of making and using same
08/15/2012CN102639487A Therapeutic aryl-am i do-aryl compounds and their use
08/15/2012CN102639145A A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
08/15/2012CN102639142A Inhibition of endosomal toll-like receptor activation
08/15/2012CN102639137A Bisphosphonate compositions and methods for treating heart failure
08/15/2012CN102639136A Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
08/15/2012CN102639135A Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
08/15/2012CN102639134A Methods of treating aneurysmal dilatation, blood vessel wall weakness and specifically abdominal aortic and thoracic aneurysm using matrix metalloprotease-2 inhibitors
08/15/2012CN102639133A Iminosugars and methods of treating bunyaviral and togaviral diseases
08/15/2012CN102639132A New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2h)-one derivatives
08/15/2012CN102639131A Sublingual dexmedetomidine compositions and methods of use thereof
08/15/2012CN102639130A Methods and compositions for treating disease or condition related to orexin receptor 1, orexin receptor 2, somatostatin receptor 2 or dopamine d2l receptor
08/15/2012CN102639129A Antimicrobial compositions containing free fatty acids
08/15/2012CN102639128A Sulfonamides for the prevention of diabetes
08/15/2012CN102639127A Composition for skin improvement comprising hexamidines and retinoids
08/15/2012CN102639126A Pterostilbene (PTER) for use in the prevention and/or treatment of skin diseases, damages or injures
08/15/2012CN102639125A Methods for treating type 2 diabetes in patients resistant to previous treatment with other anti-diabetic drugs employing an SGLT2 inhibitor and compositions thereof
08/15/2012CN102639123A Pharmaceutical solid dosage form
08/15/2012CN102639121A Orally transformable tablets
08/15/2012CN102639118A Oxidation-stabilized tamper-resistant dosage form
08/15/2012CN102639116A New oral formulations for tetrapyrrole derivatives
08/15/2012CN102639011A Composition containing fat-soluble vitamin
08/15/2012CN102639003A Compositions and methods for feeding poultry
08/15/2012CN102638983A Compositions and methods for treating colitis
08/15/2012CN102638982A Crystalline forms of (s)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorohphenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
08/15/2012CN102638981A Substituted piperidines that increase p53 activity and the uses thereof
08/15/2012CN102638979A O-benzyl nicotinamide analogs as mGluR5 positive allosteric modulators
08/15/2012CN102638978A Method for treating a patient in need of aspirin therapy
08/15/2012CN102634561A Application of triptolide, triptolide derivant and triptolide analogue in preparation of antitumor drugs
08/15/2012CN102634478A Action of improving function of endothelial progenitor cells by tripterine
08/15/2012CN102634307A Hot-melting pressure sensitive adhesive and preparation method thereof
08/15/2012CN102633899A Selenized microbial exopolysaccharide, and preparation method and uses thereof
08/15/2012CN102633893A Hypo- and hyper-acetylated meningococcal capsular saccharides
08/15/2012CN102633856A Oleanolic acid-pyrimidine conjugate as well as preparation method and application thereof
08/15/2012CN102633852A Imine stigmasterol derivative and application thereof in anti-cancer drug
08/15/2012CN102633850A Rhoifolin extraction method and usage of drug prepared by rhoifolin
08/15/2012CN102633849A Preparation method and anticancer use of iridoid catalpa glycosides
08/15/2012CN102633837A Benzocyclophosphamide phenate derivatives as well as preparation method and application thereof
08/15/2012CN102633832A Method for preparing high-purity phosphatidylcholine
08/15/2012CN102633831A Methyl phosphorus propofol disodium dihydrate and preparation method and application thereof
08/15/2012CN102633818A Cefoxitin esterified prodrug compound and oral preparation thereof
08/15/2012CN102633817A Cefoxitin esterified prodrug compound and oral preparations
08/15/2012CN102633816A Cefoxitin esterified prodrug compound and oral preparations
08/15/2012CN102633815A Cefoxitin esterified prodrug compound and oral preparation thereof
08/15/2012CN102633812A Oxazolone quinazoline derivatives as well as preparation method and application thereof
08/15/2012CN102633794A 5-substituted phenoxy-1, 2, 4-triazole [4, 3-a] pyridine compound used for antiepileptic medicament, and medical salt thereof
08/15/2012CN102633791A Application of 4-alkyl-6-aryl-5-(1,2,4-triazole-1-yl)-2-amino-1,3-thiazine to preparation of antidepressants
08/15/2012CN102633784A Two new flavone C-glycoside compounds as well as preparation method and application thereof
08/15/2012CN102633783A Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
08/15/2012CN102633780A Nitric oxide donor with thrombin inhibition effect, as well as preparation method and medical application thereof
08/15/2012CN102633777A Dabigatran etexilate 2-ketoglutarate as well as preparation method and application thereof
08/15/2012CN102633774A Methionine or oxidized methionine modified Clinafloxacin and application thereof
1 ... 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 ... 7860